InnoCom Bio Equities Revenue

Venture Capital and Private Equity Principals • San Francisco, California, United States • 1-10 Employees

InnoCom Bio Equities revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Venture Capital and Private Equity Principals industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at InnoCom Bio Equities

Mary Patton

Managing Director and Scientific Advisory Board member

Company overview

Headquarters	San Francisco, California, United States
Website	innocombio.com
NAICS	52391
Keywords	Venture Capital, Financial Leadership, Operations Leadership
Founded	2020
Employees	1-10

About InnoCom Bio Equities

InnoCom's investment fund offers a unique opportunity to contribute to critical medical advancements, with a current portfolio of thirteen companies that have invested over $165 million in solutions for cancer, COVID-19, and more. The fund is projected to deliver substantial returns, with outside experts estimating a six-year valuation of $350 billion and very attractive potential investor returns as well. InnoCom's Principals, experienced C-level executives, actively support each portfolio company, enabling them to focus more specifically on scientific innovation and sustainable product realization. The fund's risk is mitigated by its diversity, hands on Strategic and Operational care and an early commercialization strategy bolstered by strong ties with the veterinary community on the way to human clinical approval worldwide.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

InnoCom Bio Equities has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

InnoCom Bio Equities has never raised funding before.

Frequently asked questions

InnoCom Bio Equities is located in San Francisco, California, US.

InnoCom Bio Equities generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

InnoCom Bio Equities has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

InnoCom Bio Equities was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

InnoCom Bio Equities has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at InnoCom Bio Equities

Mary Patton

Managing Director and Scientific Advisory Board member

4.8

40,000 users